作者

Christoph de Coster, LL.M. (UC Davis)

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr. Jan Phillip Rektorschek

合伙人

Read More

Verena Bertram

授薪合伙人

Read More

Dr. Nora E. Wessendorf, LL.M. (Washington)

授薪合伙人

Read More
作者

Christoph de Coster, LL.M. (UC Davis)

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr. Jan Phillip Rektorschek

合伙人

Read More

Verena Bertram

授薪合伙人

Read More

Dr. Nora E. Wessendorf, LL.M. (Washington)

授薪合伙人

Read More

2019年3月19日

JUVE Nachricht vom 19.03.2019 - Generics manufacturers prevail over Hogan Lovells client MSD

Various generics manufacturers have won in the second instance in the dispute over supplementary protection certificates for cholesterol-lowering drug Inegy. The Higher Regional Court Düsseldorf dismissed the appeal of US originator Merck Sharp Dome (MSD) (case IDs: I-2 U 58/18 - I-2 U 64/18 and I-2 U 82/18). The various pharmaceutical companies may continue to market imitation products in Germany, using the active substance combination ezitimibe and simvastatin.

Read the whole article Generics manufacturers prevail over Hogan Lovells client MSD.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

加密资产、区块链和分布式账本技术

Bits and pieces from the Metaverse

Issue #12

2022年10月10日
Quick read

作者

点击此处了解更多
加密资产、区块链和分布式账本技术

Bits and pieces from the Metaverse

Issue #11

2022年9月26日
Quick read

作者

点击此处了解更多
专利与创新

Pharma cases: No proportionality defence without (expedited) request for compulsory license

2022年9月14日
Briefing

作者 Verena Bertram 以及 Dr. Nora E. Wessendorf, LL.M. (Washington)

点击此处了解更多